国仪量子冲击科创板，面向量子科技等领域，三年半亏损超4亿

Core Viewpoint - The article highlights the growing interest and investment in quantum technology, particularly in the context of China's "14th Five-Year Plan," which includes quantum technology as a strategic growth point for the new economy. The IPO wave in the quantum technology sector is beginning, with Guoyi Quantum Technology (Hefei) Co., Ltd. filing for an IPO on the Sci-Tech Innovation Board [1]. Company Overview - Guoyi Quantum focuses on the research and development of high-end scientific instruments, providing advanced scientific equipment and solutions for various fields, including quantum technology, materials science, and biomedicine [1][4]. - The company has launched several products, including electron paramagnetic resonance spectrometers and scanning electron microscopes, breaking the long-standing dominance of international giants in certain segments of the domestic market [4]. Revenue Composition - From 2022 to the first half of 2025, the revenue share from quantum information technology and spin resonance decreased from 49.32% to 25.26%, while the revenue share from electron microscope series increased from 24.46% to 56.02% [5][6]. - The company’s revenue figures for the years 2022 to 2025 (first half) are approximately 151 million, 400 million, 501 million, and 171 million respectively, with corresponding net losses of approximately -129 million, -146 million, -86 million, and -76 million [11]. Market Dynamics - The global market for laboratory analytical instruments is projected to grow from $82.95 billion in 2024 to $101.58 billion by 2029, with an average annual growth rate of 4.1% [12]. - China's laboratory analytical instrument market is expected to reach $9.28 billion in 2024, with a compound annual growth rate of 4.7% from 2024 to 2029, positioning it as the second-largest market among major economies [14]. Competitive Landscape - The high-end scientific instrument market in China has been dominated by foreign manufacturers, with over 75% of large scientific instruments in universities and research institutions being imported [18]. - Guoyi Quantum faces challenges in terms of historical accumulation, operational scale, product matrix, financial strength, market share, and brand recognition compared to established players like Thermo Fisher and Agilent [18]. Management and IPO Details - Guoyi Quantum, established in 2016, is led by a young management team, including a 1992-born chairman and general manager, He Yu, who has a PhD from the University of Science and Technology of China [21]. - The company aims to raise approximately 1.169 billion for projects related to high-end scientific instrument industrialization, quantum technology research, and application center network construction [22].